Table 3.
Intervention group scale analysis: More than half post-test responses showing HPV Knowledge and HPV vaccination acceptance.
| Scale | Control a (n = 277) | Exp. Group 1 b (n = 285) | Exp. Group 2 c (n = 261) | Exp. Group 3 d (n = 286) | Across/between Groups Comparison | ||
|---|---|---|---|---|---|---|---|
| Kruskal-Wallis Mean Rank | Kruskal-Wallis Mean Rank | Kruskal-Wallis Mean Rank | Kruskal-Wallis Mean Rank | Chi-Square | df | p Value | |
| Knowledge Subscale | |||||||
| Change > half overall Responses Agree or Strongly Agree | 517.89 | 540.04 | 585.31 | 578.18 | 8.443 | 3 | 0.038 * |
| 3. HPV causes genital warts | 514.47 | 506.13 | 604.96 | 597.37 | 34.887 | 3 | <0.001 ** |
| 9. I know what the HPV vaccine is for | 522.18 | 548.34 | 561.97 | 587.06 | 8.556 | 3 | 0.036 * |
| Acceptance Subscale | |||||||
| Change > half Overall Responses Agree or Strongly Agree | 531.84 | 571.39 | 550.14 | 565.53 | 2.628 | 3 | 0.453 |
a (n = 277) is the number of participants in the Control group. b (n = 285) is the number of participants in Experimental Group 1. c (n = 261) is the number of participants in Experimental Group 2. d (n = 286) is the number of participants in Experimental Group 3. * denotes significant 2-tailed correlation at the alpha = p = 0.05 level. df = degrees of freedom; ** denotes significant 2-tailed correlation at the alpha = p = 0.01 level; ; Exp. = Experimental.